Indefinite Delivery Contract 36C26224D0170

Award Date 9/16/24
Last Date to Order 9/15/26
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This federal contract IDV award to Central Admixture Pharmacy Services Inc. (CAPS), doing business as Caps, is for the provision of compounded sterile preparations and pharmacy services, including total parenteral nutrition (TPN) solutions, sterile admixtures, and various compounded medications. The $382,475.66 Indefinite Delivery Contract (IDC) was awarded in August 2022 by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 15 (VISN 15) and has an ultimate completion...
This indefinite delivery contract (IDC) was awarded by the U.S. Department of Veterans Affairs (VA) VISN 10 network to Central Admixture Pharmacy Services, Inc. (Caps) for the provision of patient-specific total parenteral nutrition (TPN), lipid emulsion, and cardioplegia orders for the Lt. Col. Charles S. Kettles VA Medical Center. The contract has a ceiling value of $826,242.00 and a period of performance from January 5, 2025 to January 4, 2030. Caps is an established provider of compounded...
This Indefinite Delivery Contract (IDC) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 10 to Central Admixture Pharmacy Services, Inc. (CAPS), a leading provider of compounded sterile pharmaceutical preparations and specialized pharmacy services to U.S. government agencies. The $444,583.70 IDC is for the provision of PHARMACY COMPOUNDING SERVICES FOR TOTAL PARENTERAL NUTRITION to support patient care at VA healthcare facilities. CAPS operates as both a...
Central Admixture Pharmacy Services Inc. (CAPS) has been awarded a single-award Indefinite Delivery Contract (IDC) worth up to $455,204 by the Defense Health Agency (DHA) to provide CAPS Sterile Admixture products and services. The base period of performance runs through September 30, 2026. CAPS, a large established provider in the field of customized sterile pharmaceutical preparations, has been issued multiple delivery orders under this IDC to supply a variety of sterile intravenous...
Central Admixture Pharmacy Services, Inc. (CAPS), a provider of compounded sterile preparations and pharmacy services, has been awarded a $6.5 million Blanket Purchase Agreement (BPA) by the Defense Health Agency (DHA). Under this IDV, CAPS will deliver a variety of compounded admixture medicines, total parenteral nutrition, and other sterile pharmaceutical products to support DHA medical programs. The contract has a period of performance through July 14, 2026, with no set-aside designation....
The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center has awarded a $6 million, single-award Indefinite Delivery Contract (IDC) to Central Admixture Pharmacy Services Inc. (Caps) for the provision of 503A compounded sterile preparations and parenteral nutrition solutions. Caps is a for-profit organization that operates as both a 503A traditional pharmacy and a 503B outsourcing facility, specializing in customized intravenous mixtures, sterile admixtures,...
The federal contract IDV award is a Blanket Purchase Agreement (BPA) between the Department of Veterans Affairs (VA), Veterans Integrated Service Network 19 and the College of American Pathologists (CAP), a non-profit organization. The contract has a total ceiling value of $169,714.77 and runs through October 19, 2028. Under this BPA, CAP is the prime contractor providing clinical laboratory quality assurance products and services to the VA, including proficiency testing, accreditation programs,...
The federal contract IDV award is for a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the Department of Veterans Affairs. The prime contractor, CMP Pharma Inc., provides a variety of pharmaceutical products, primarily creams and suspensions, such as TAC/EUCERIN, TRIAMCINOLONE/ABSORBASE, and SPS SUSP. The contract has a ceiling value of $4,500,000.00 and a period of performance...
This federal contract IDV award, V797D50461, is a GSA Federal Supply Schedule (FSS-65-II-A) for Medical Equipment and Supplies, held by Capsa Solutions LLC (doing business as Capsa Healthcare). The $7.4 million ceiling contract has been active since August 2015 and provides a vehicle for Capsa to deliver a wide range of medical equipment and storage solutions to various government agencies, primarily the Department of Veterans Affairs (VA). Capsa, a for-profit, small business manufacturer, has...
The federal contract IDV award is a Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs (FSS-61-IB) schedule, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs (VA). The prime contractor is Amphastar Pharmaceuticals, Inc., a for-profit manufacturer of pharmaceutical goods. The $58,244,500 multiple award contract has a period of performance through January 14, 2027 and aims to procure a broad range of drug,...
  • 36C26224D0170
    Indefinite Delivery Contract
  • 4
    Federal Contract Awards

This federal contract IDV, awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 22 (VISN 22), is for the procurement of pharmacy products and services from Central Admixture Pharmacy Services, Inc. (doing business as Caps). Caps is a leading provider of compounded sterile pharmaceutical preparations, including total parenteral nutrition (TPN) solutions, sterile admixtures, and other specialized intravenous medications, to various U.S. government healthcare agencies. The IDV, valued at $4,000,000, is a single-award Indefinite Delivery Contract with a period of performance from September 16, 2024 to September 15, 2026. It does not utilize any set-aside designations.

Under this IDV, the VA has issued several delivery orders to Caps, ranging in value from $123,350 to $205,160, for the provision of TPN supplies and services to participating VA medical centers within VISN 22. These task orders are firm fixed-price contracts that allow the VA to efficiently procure Caps' specialized pharmaceutical products and services on an as-needed basis to support patient care programs. The original solicitation sought to establish this IDIQ contract for TPN supplies and services, aligning with Caps' core capabilities as a 503A pharmacy and 503B outsourcing facility serving federal healthcare providers.

Generated 7/17/25, 2:37 PM